ArticleFrontiers in oncology2026
Interpretable machine learning for prediction of leptomeningeal metastasis in lung adenocarcinoma: a multi-centre retrospective study via "Prompt" model.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Leptomeningeal metastasis (LM) is a serious complication of lung adenocarcinoma (LUAD). Owing to the difficulty in early diagnosis and the limited clinical benefit of available treatments, affected patients experience extremely poor outcomes. Thus, the machine-learning-enhanced predictive framework Prompt was developed to optimise early clinical identification and prognostic assessment. This model was designed to determine major risk factors for LM in patients with LUAD, estimate the possibility of LM onset and predict survival, thereby supporting clinical decision-making via an early-warning system and accurate survival prediction. Methods: Clinical data of patients diagnosed with LUAD complicated by LM (LUAD-LM) between 1 January 2012 and 1 January 2025 were obtained from electronic medical databases across multiple medical centres. Embedded feature selection was conducted using tree-based feature importance ranking. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) to determine the most suitable machine-learning model. Shapley additive explanation (SHAP) values were applied to interpret the high-risk diagnostic model, and survival outcomes were examined using Cox proportional hazards regression. Results: Among 6,784 screened LUAD cases, 181 individuals met the inclusion criteria for patients with confirmed LUAD-LM. A high-risk diagnostic model for LUAD-LM was developed using the Tabular Prior-data Fitted Network (TabPFN), an approach recently published in Conclusion: Prompt framework delivers exploratory LM risk and survival estimations for Chinese patients with LUAD, serving as a preliminary risk-stratification reference rather than a universally applicable clinical diagnostic tool pending prospective external validation across diverse populations and healthcare systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.